Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology · 2013
[The changes in serum concentrations of interleukin-17 in diseases gastroduodenal zone].
СтатьяНазвание и аннотация: Оригинал на русском
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Matveeva L V, Mosina L M
Аннотация
THE PURPOSE OF THE STUDY: Identify on patients with chronic gastritis, peptic ulcer disease, gastric cancer, serum concentrations of interleukin-17 and its relationship to clinical and morphological and serological characteristics.
MATERIAL AND METHODS: A comprehensive survey of 156 patients with diseases gastroduodenal zone. Diagnostic emphasis was placed on ELISA method as defined in the serum of IL-17, pepsinogen-I, - II, total antibodies to CagA Helicobacter pylori.
RESULTS: In studied patients revealed changes in the concentration of interleukin-17 correlate with the stage of atrophy of the gastric mucosa, tumor, level of pepsinogen, antibodies to the Helicobacter pylori.
CONCLUSION: The data obtained allow to recommend the use of interleukin-17 in serological differential diagnosis of diseases gastroduodenal zone.
MATERIAL AND METHODS: A comprehensive survey of 156 patients with diseases gastroduodenal zone. Diagnostic emphasis was placed on ELISA method as defined in the serum of IL-17, pepsinogen-I, - II, total antibodies to CagA Helicobacter pylori.
RESULTS: In studied patients revealed changes in the concentration of interleukin-17 correlate with the stage of atrophy of the gastric mucosa, tumor, level of pepsinogen, antibodies to the Helicobacter pylori.
CONCLUSION: The data obtained allow to recommend the use of interleukin-17 in serological differential diagnosis of diseases gastroduodenal zone.